Literature DB >> 7834567

Duchenne muscular dystrophy: negative scotopic bright-flash electroretinogram and normal dark adaptation.

F Tremblay1, I De Becker, D C Riddell, J M Dooley.   

Abstract

Recent reports indicate that most subjects with Duchenne muscular dystrophy (DMD) have a negative scotopic bright-flash electroretinogram (ERG). We performed dark adaptometry in seven patients with the DMD phenotype. Three patients had the negative bright-flash response combined with severely reduced rod-related activity; their mean psychophysical dark-adapted threshold was -5.5 +/- 0.3 (normally -5.4 +/- 0.3) cd.m-2. Two of the three patients were able to sit through the complete test: the profile of their dark adaptation curve was normal. The four other patients had a normal scotopic ERG, and their mean psychophysical dark-adapted threshold was -5.3 +/- 0.3 cd.m-2. One of the four was able to complete the entire procedure, and a normal profile was found. In patients with DMD the dark adaptation measurements are normal despite abnormalities in rod-related ERG activity.

Entities:  

Mesh:

Year:  1994        PMID: 7834567

Source DB:  PubMed          Journal:  Can J Ophthalmol        ISSN: 0008-4182            Impact factor:   1.882


  4 in total

Review 1.  Mouse b-wave mutants.

Authors:  Machelle T Pardue; Neal S Peachey
Journal:  Doc Ophthalmol       Date:  2014-01-07       Impact factor: 2.379

2.  Red-green color vision impairment in Duchenne muscular dystrophy.

Authors:  Marcelo Fernandes Costa; Andre Gustavo Fernandes Oliveira; Claudia Feitosa-Santana; Mayana Zatz; Dora Fix Ventura
Journal:  Am J Hum Genet       Date:  2007-04-13       Impact factor: 11.025

3.  Verifying complaints of difficulties in night vision using electroretinography and dark adaptation tests.

Authors:  Gilad Allon; Yolanda Friedrich; Eedy Mezer; Aviran Itzhaki; Rina Leibu; Ido Perlman
Journal:  Doc Ophthalmol       Date:  2019-10-16       Impact factor: 2.379

Review 4.  Electrophysiological analysis of visual function in mutant mice.

Authors:  Neal S Peachey; Sherry L Ball
Journal:  Doc Ophthalmol       Date:  2003-07       Impact factor: 1.854

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.